Carbamazepine Extended-Release Capsules (Carbatrol) and Elbasvir and grazoprevir
Determining the interaction of Carbamazepine Extended-Release Capsules (Carbatrol) and Elbasvir and grazoprevir and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using grazoprevir together with carBAMazepine is not recommended. Combining these medications may significantly reduce the blood levels of grazoprevir, which may make the medication less effective in treating hepatitis C. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:CONTRAINDICATED: Coadministration with potent inducers of CYP450 3A4 may significantly decrease the plasma concentrations of elbasvir and grazoprevir, both of which are substrates of the isoenzyme. In 10 study subjects, administration of elbasvir 50 mg once daily with efavirenz 600 mg once daily decreased elbasvir peak plasma concentration (Cmax), systemic exposure (AUC) and trough plasma concentration (Cmin) by 45%, 54% and 59%, respectively, compared to administration of elbasvir alone. Likewise, when grazoprevir 200 mg once daily and efavirenz 600 mg once daily were given together to 12 study subjects, grazoprevir Cmax, AUC and Cmin decreased by 87%, 83% and 69%, respectively. Efavirenz is generally considered a moderate inducer of CYP450 3A4. More potent inducers such as carbamazepine or phenytoin may interact to an even greater extent.
MANAGEMENT: Given the risk of reduced viral susceptibility and resistance development associated with subtherapeutic antiviral drug levels, concomitant use of elbasvir-grazoprevir with efavirenz or potent CYP450 3A4 inducers is considered contraindicated.
- "Product Information. Zepatier (elbasvir-grazoprevir)." Merck & Company Inc, Whitehouse Station, NJ.
Generic Name: carbamazepine
Brand name: Carbatrol, Epitol, Equetro, Tegretol, Tegretol XR, Tegretol, Tegretol XR
Synonyms: Carbamazepine, CarBAMazepine
Generic Name: elbasvir / grazoprevir
Brand name: Zepatier
Synonyms: Elbasvir and Grazoprevir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbamazepine Extended-Release Capsules (Carbatrol)-Eldepryl
- Carbamazepine Extended-Release Capsules (Carbatrol)-Eldepryl Capsules
- Carbamazepine Extended-Release Capsules (Carbatrol)-Eldepryl Oral
- Carbamazepine Extended-Release Capsules (Carbatrol)-Eldepryl Tablets
- Carbamazepine Extended-Release Capsules (Carbatrol)-ELenzaPatch
- Carbamazepine Extended-Release Capsules (Carbatrol)-Elepsia XR
- Elbasvir and grazoprevir-Carbamazepine Extended-Release Capsules (Equetro)
- Elbasvir and grazoprevir-Carbamazepine Extended-Release Tablets
- Elbasvir and grazoprevir-Carbamazepine Intravenous
- Elbasvir and grazoprevir-Carbamazepine Oral Suspension
- Elbasvir and grazoprevir-Carbamazepine Tablets
- Elbasvir and grazoprevir-Carbaphen 12